Cite
HARVARD Citation
Guelen, L. et al. (2022). Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy. Journal for immunotherapy of cancer. 10 (9), p. . [Online].